Full Text
CH1- COST-EFFECTIVENESS ANALYSIS OF IRINOTECAN AS FIRST-LINE THERAPY IN ADVANCED COLORECTAL CANCER

Abstract

Authors

C Schmitt C Levy-Piedbois M Frappe I Durand-Zaleski

Back to Volume 3, Issue 5
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×